Scale up of the production of mesenchymal stem cells derived from human adipose tissue for their differentiation into insulin-producing and glucagon-producing cells. A cell therapy for diabetes
University: University of Chile
Researchers: Anamaría Sánchez, Lorna León, Esteban González, Ziomara Gerdtzen, Pablo Caviedes, Barbara Andrews, Juan A. Asenjo
A process for the expansion and differentiation of mesenchymal stem cells obtained from adipose tissue to insulin-producing and glucagon-producing cells for potential cell therapy.
Cell therapy, biomedical industry, human health, academia.
Generate a structure that is most similar to a pancreatic islet, in sufficient quantity and quality to implant in insulin-dependent diabetic patients, and recover its ability to regulate glycemia.